Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.06EUR
120.90 MEUR
1.99 BEUR
1.61 B
About CONVATEC GROUP PLC ORD GBP0.1
Sector
Industry
CEO
Karim Sani Nasib Bitar
Website
Headquarters
Paddington
Employees (FY)
10.14 K
Founded
1978
ISIN
GB00BD3VFW73
FIGI
BBG00F38S4L3
ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.
Convatec - Chronically undervalued?Buy Convatec (CTEC.L)
ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and inf
Godd reaction to yesterday's resultsOn weekly chart dark cloud cover is usually bearish,
but this week's price action could make the stock bullish.
It still has to pull away from 219p resistance though.
CTEC - Convatec - BuyA very simple trade here. MACD & RSI diverging at support. Good R/R ratio with stops @ 180.5 and 1st target @ 219
Convatec ~ Long Swing TradeShowing signs of a new uptrend.
Hold till resistance level/ an overbought RSI.
Place stop loss at 200.
Risk/Reward ratio: 4
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CONVATEC GROUP WI LS -,10 stocks are traded under the ticker 2CV.
CONVATEC GROUP WI LS -,10 is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
2CV earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.05 EUR resulting in a 16.64% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about CONVATEC GROUP WI LS -,10 earnings.
CONVATEC GROUP WI LS -,10 revenue for the last quarter amounts to 967.69 M EUR despite the estimated figure of 945.23 M EUR. In the next quarter revenue is expected to reach 993.69 M EUR.
Yes, you can track CONVATEC GROUP WI LS -,10 financials in yearly and quarterly reports right on TradingView.
2CV net income for the last quarter is 68.67 M EUR, while the quarter before that showed 52.56 M EUR of net income which accounts for 30.64% change. Track more CONVATEC GROUP WI LS -,10 financial stats to get the full picture.
CONVATEC GROUP WI LS -,10 dividend yield was 2.01% in 2023, and payout ratio reached 95.27%. The year before the numbers were 2.18% and 201.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2CV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONVATEC GROUP WI LS -,10 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has 10.14 K employees. See our rating of the largest employees — is CONVATEC GROUP WI LS -,10 on this list?
We've gathered analysts' opinions on CONVATEC GROUP WI LS -,10 future price: according to them, 2CV price has a max estimate of 4.33 EUR and a min estimate of 2.63 EUR. Read a more detailed CONVATEC GROUP WI LS -,10 forecast: see what analysts think of CONVATEC GROUP WI LS -,10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONVATEC GROUP WI LS -,10 EBITDA is 464.85 M EUR, and current EBITDA margin is 23.37%. See more stats in CONVATEC GROUP WI LS -,10 financial statements.